Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines-Reference-Cited by-同舟云学术

Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines

Published:2014-06-20 Issue: Volume:4 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Davidson Brittany Anne,Rubatt Jennifer M.,Corcoran David L.,Teoh Deanna K.,Bernardini Marcus Q.,Grace Lisa A.,Soper William John,Berchuck Andrew,Siamakpour-Reihani Sharareh,Chen Wei,Owzar Kouros,Murphy Susan K.,Secord Angeles Alvarez

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference31 articles.

1. Angiogenesis: an update;Diaz-Flores;Histol Histopathol,1994

2. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor expression in tumors;Mukhopadhyay;Semin Cancer Biol,2004

3. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression;Mukhopadhyay;Cancer Res,1995

4. Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism;Galy;Oncogene,2001

5. The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer;Goodheart;Clin Cancer Res,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic risk factors of serous ovarian carcinoma based on mesenchymal stem cell phenotype and guidance for therapeutic efficacy;Journal of Translational Medicine;2023-07-11

2. Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity;Life Sciences;2022-08

3. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management;International Journal of Molecular Sciences;2022-03-17

4. Progression inference for somatic mutations in cancer;Heliyon;2017-04

5. Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with Cisplatin;Journal of Nanomaterials;2017